Lower observed-to-expected ratios were seen for cases diagnosed at localized versus advanced stages.
Faster AI imaging can produce more nuanced cancer treatments, developers say
By
Aaron Dorman
Sep 14, 2023
A new AI program can use images of a person’s body and organs to evaluate for cancer treatment within several minutes — much faster than current methods, researchers say.
AACR cancer progress report reveals 33 percent decrease in cancer death rate, 1990 to 2020
Sep 13, 2023
The report highlights advances such as approval of 14 new anticancer therapeutics and the expansion of the use of 12 previously approved therapeutics.
17 percent of patients seeing neurologist travel long distance
Sep 13, 2023
Factors associated with long-distance travel include low neurologist density, rural setting and visits for ALS and nervous system cancer.
California Legislature first to pass ban on four food additives linked to health issues
Sep 13, 2023
The chemicals already are illegal in the European Union and other places around the world.
Rice-sized device could have big implications for brain tumor treatments
By
Aaron Dorman
Sep 12, 2023
A small implantable device, the size of a grain of rice, could be placed in the brain of cancer patients to help develop treatments, new research suggests.
Red Cross appeals for donors during national blood shortage
Sep 11, 2023
Back-to-back climate-related disasters have hampered blood collection efforts, and a summer shortfall has made the shortage worse.
Even five years postapproval, many drug studies remain nonpublic
Sep 01, 2023
The authors urge greater transparency of study results for drugs approved by the FDA.
Adherence to Mediterranean lifestyle linked to lower mortality
Aug 29, 2023
Increasing quartiles of MEDLIFE index were associated with reduced hazard ratios for all-cause and cancer mortality.
Heart, diabetes, cancer drugs on list for Medicare price negotiations, White House says
Aug 29, 2023
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.
